Clinical Trial: A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975462) titled 'A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases' on May 09.

Brief Summary: A prospective, single-arm study to explore the efficacy and safety of SHR-A1811 combined with radiotherapy in patients with HER2-positive or HER2-low brain metastases

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Breast Cancer Metastatic

Intervention: COMBINATION_PRODUCT: SHR-A1811 and radiotherapy

SHR-A1811:4.8mg/kg radiotherapy: 800cGY*5

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Wuhan Union Hospital, China

Published by HT Digital Content Services with perm...